Home › Researcher directory › Olfa Hazgui
Olfa Hazgui
Affiliation : Hôpital Farhat Hached
- 15Publications (affiliation in Tunisia)
- 18Total publications
- 115Citations
- 5h-index
Research profile
Olfa Hazgui has 15 indexed publications (2017–2026). Their work appears mainly in “International Journal of Infectious Diseases”, “European Journal of Public Health” and “Vaccine”. Their most cited article, “Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy” (2020), has been cited 51 times. Their work is co-authored with at least 12 researchers, including institutions in Austria.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Herpesvirus Infections and Treatments
- Viral-associated cancers and disorders
- Cytomegalovirus and herpesvirus research
- Hepatitis B Virus Studies
- Vaccine Coverage and Hesitancy
Publications (15)
- National Prevalence and Risk Factors of Hepatitis B Virus Infection in Tunisia Two Decades After Vaccine Introduction
- Human herpesvirus-8 infection in Tunisian adult acute leukemia patients
- Pooling Nasopharyngeal Swab Specimens to Improve Testing Capacity for SARS-CoV-2 by Real-Time RT-PCR
- Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study
- Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy
- Human adenoviruses associated with respiratory illness in neonates, infants, and children in the Sousse area of Tunisia
- Presence of cytomegalovirus and human herpesvirus 6 in-patients with lymphomas
- HHV-6 infection in non-transplant acute leukemia patients during chemotherapy
- Hépatite B en Tunisie. Épidémiologie, facteurs de risque et impact de la vaccination
- Prevalence and risk factors of hepatitis B in Tunisia
- Corrigendum to ‘Observational study of vaccine effectiveness 20 years after the introduction of universal hepatitis B vaccination in Tunisia’ [Vaccine 36 (2018) 5858–5864]
- Impact of hepatitis B vaccine in Tunisia 20 years after its introduction
- Observational study of vaccine effectiveness 20 years after the introduction of universal hepatitis B vaccination in Tunisia
- 2e Congrès international militaire de médecine tropicale et de voyage couplé avec le 1er Congrès national de la Société tunisienne de médecine tropicale et de voyage et les Journées délocalisées de la Société française de médecine des voyages, Tozeur, Tunisie du 11 au 13 octobre 2018
- Increased levels of soluble HLA ‐G molecules in Tunisian patients with chronic hepatitis B infection
Publication venues
- International Journal of Infectious Diseases × 2
- European Journal of Public Health × 2
- Vaccine × 2
- Vaccines × 1
- African Health Sciences × 1
- Biological Procedures Online × 1
Publications per year
- 20261
- 20231
- 20212
- 20204
- 20194
- 20182
- 20171
Collaborations
Partner institutions : University of Sousse · Tunis El Manar University · Tunis University · Faculté de médecine de Tunis · University of Sfax
Co-authors’ countries : Austria
Co-authors
- Naïla Hannachi
- Jalel Boukadida
- Imene Handous
- Manel Marzouk
- Nissaf Bouafif Ben Alaya
- Abderrahim Khélif
- Béchir Achour
- Olfa Bahri
- Inès Brini
- Hédia Bellali
- Hamza Ben Yahia
- Saloua Jemni Yacoub
Bibliographic data from OpenAlex (open database).
Why choose Dzcademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.